non-small-cell-lung-cancer

Documents about non-small-cell-lung-cancer

• Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer#837694ClinicalTrials.gov
• SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer#287545ClinicalTrials.gov
• Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung Cancer#141081ClinicalTrials.gov
• Neoadjuvant Therapy in Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB#195298ClinicalTrials.gov
• Biodistribution and Kinetics of 18F-AraG in Non-Small Cell Lung Cancer#407730ClinicalTrials.gov
• Imaging Tumor-infiltrating T-cells in Non-small Cell Lung Cancer#435724ClinicalTrials.gov
• Radiotherapy Combined With Immunotherapy for Brain Metastases of Non-small Cell Lung Cancer#623506ClinicalTrials.gov
• Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer#674898ClinicalTrials.gov
• Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research#804702ClinicalTrials.gov
• Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer#827174ClinicalTrials.gov
• Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer#805135ClinicalTrials.gov
• D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC)#349957ClinicalTrials.gov
• Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer#398316ClinicalTrials.gov
• Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer#268010ClinicalTrials.gov
• Vismodegib and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer#405142ClinicalTrials.gov
• Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer#143782ClinicalTrials.gov
• BIO 300 Non-Small Cell Lung Cancer Study#830986ClinicalTrials.gov
• Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer#830689ClinicalTrials.gov
• Neoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung Cancer#121367ClinicalTrials.gov
• Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer#238093ClinicalTrials.gov
• T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung Cancer#321689ClinicalTrials.gov
• Neoadjuvant Toripalimab Plus Platinum-based Doublet for Stage III Non-small Cell Lung Cancer#467595ClinicalTrials.gov
• A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer#811292ClinicalTrials.gov
• Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer#812028ClinicalTrials.gov
• Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer#343837ClinicalTrials.gov
• Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)#172370ClinicalTrials.gov
• Artificial Intelligence for Help Non-Small Cell Lung Cancer: Measure Cancer Biology and Treatment Response Via Imaging#222408ClinicalTrials.gov
• Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer#249582ClinicalTrials.gov
• Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer#398303ClinicalTrials.gov
• A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer#373617ClinicalTrials.gov
• CCCR-NK92 Cells Immunotherapy for Non-small Cell Lung Carcinoma#346917ClinicalTrials.gov
• Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer#840235ClinicalTrials.gov
• Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer#806753ClinicalTrials.gov
• A Study of Anti-PD-1 AK105 in Patients With Metastatic Squamous Non-small Cell Lung Cancer#303718ClinicalTrials.gov
• A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC#835883ClinicalTrials.gov
• Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer#839400ClinicalTrials.gov
• Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer#245508ClinicalTrials.gov
• Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer#834847ClinicalTrials.gov
• Prevention of Radiation Pneumonitis After Three-dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-small-cell Lung Cancer#839217ClinicalTrials.gov
• Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer#839689ClinicalTrials.gov
• Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer#807260ClinicalTrials.gov
• Similar Efficacy, Safety, and Immunogenicity of FYB206 in Comparison to Keytruda as add-on to Chemotherapy in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC)#287528ClinicalTrials.gov
• Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer#307450ClinicalTrials.gov
• FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer#321682ClinicalTrials.gov
• Prediction of Response to Treatment With Immunotherapy + Chemotherapy in Non-Small Cell Lung Cancer#377406ClinicalTrials.gov
• Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere)#840106ClinicalTrials.gov
• A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer#805583ClinicalTrials.gov
• A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer#807545ClinicalTrials.gov
• Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer#349972ClinicalTrials.gov
• Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)#201767ClinicalTrials.gov